Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon Lambda-1a in Outpatients With Mild COVID-19
NCT04331899Phase 2Completed
- Sponsor
- Stanford University
- Start
- Apr 2020
- Primary completion
- Aug 2020
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon lambda-1a in coronavirus disease 2019 (COVID-19), sponsored by Stanford University. Started Apr 2020; status: completed.
02
Drugs
peginterferon lambda-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04331899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04331899.